Abstract

The human microbiome has emerged as the crucial moderator in the interactions between food and our body. It is increasingly recognised that the microbiome can change our mind and health status, or switch on a wide range of diseases including cancer, cardio-metabolic diseases, allergies, and obesity. The causes of diseases are often only partially understood. However, nutrients, metabolites, and microbes are increasingly regarded as key players, even where the complete disease mechanisms remain unclear. The key to progress in the future will be to use and exploit additional, newly emerging disciplines such as metagenomics to complement patient information and to bring our understanding of diseases and the interrelation and effects of nutritional molecules to the next level. The EU has already funded 216 projects under the 7th Framework Programme and Horizon 2020 programmes to promote metagenomics and to advance our knowledge of microbes. This support started with the catalysing MetaHIT project that has produced a catalogue of gut microbes, and has arrived now at the very multi-disciplinary SYSCID action looking at how the microbiome is driving its resilience potential and our health. Together, these projects involve an investment of more than €498 M. However, in Horizon 2020, the new EU Health and Food Work Programmes for 2018–2020 go even further by setting new goals to find applications and to generate more knowledge on the microbiome, nutrition, various hosts of microbes, and their relation to health and disease. The big vision is to modulate health and diseases via the microbiome and nutrition, while at the same time other factors such as omics, molecular signatures, and lifestyle are constant. In this way, microbiome and nutrition research is moving from an isolated and despised offside position to a beacon of hope with a lot of potential and possibilities.

Highlights

  • Personalised medicine aims to develop tailor-made diagnostic, treatment, and prevention approaches using the individual characteristics of patients1

  • Microbiome in Health and Nutrition sequencing and understanding over 100 trillion bacteria living in the gut and elsewhere in the human body (American Academy of Microbiology, 2013)

  • The EU has been committed to metagenomics and microbiome research, with investments of €498 M in 216 projects (Table 1) under the latest two framework programmes for research and technological development, the 7th Framework Programme (FP7)2 and Horizon 2020 (H2020)3

Read more

Summary

Introduction

Personalised medicine aims to develop tailor-made diagnostic, treatment, and prevention approaches using the individual characteristics of patients. Personalised medicine aims to develop tailor-made diagnostic, treatment, and prevention approaches using the individual characteristics of patients1 It has been pushed by advances in molecular profiling and omics disciplines that allow a deeper understanding and better targeted strategies differing from person to person. Metagenomics has evolved to learn more about the hidden diversity of microbes living with us This discipline had the major challenges of Microbiome in Health and Nutrition sequencing and understanding over 100 trillion bacteria living in the gut and elsewhere in the human body (American Academy of Microbiology, 2013). Citizens increasingly like to collect their own lifestyle and nutritional data Integration of these data into the comprehensive health assessment could help to get even more complete health pictures, allowing the best treatment and prevention strategies. More detailed descriptions of the projects’ tasks, objectives, and goals can be found on CORDIS and on the projects’ websites

Objectives
Methods
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.